We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Age of Stored Blood Affects Cardiac Surgery Success

By HospiMedica staff writers
Posted on 31 Mar 2008
A new study has found that cardiac surgery patients who received transfusions of blood that had been stored for 2 weeks or less had lower rates of complications and death than those who received blood that was older.

Researchers at the Cleveland Clinic Foundation (OH, USA) examined data from 6,002 patients given red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG), heart-valve surgery, or both between June 30, 1998, and January 30, 2006. More...
The researchers compared a total 2,872 cardiac surgery patients who received transfusion blood that had been donated within the previous 2 weeks with 3,130 cardiac surgery patients who received transfusion blood that had been donated more than 2 weeks earlier. Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes.

The researchers found that the patients who were given older blood had a higher risk of dying in hospital than their newer blood counterparts were (2.8% versus 1.7%), and significantly more likely to need prolonged ventilation support, experience kidney failure, sepsis, or multiple organ failure. Mortality at one year was significantly less in patients given newer blood (7.4%) compared to those given older blood (11%). The investigators also discovered a direct dose response relationship between days of storage and the chances of a combination of serious complications or adverse events. After eliminating potential confounding factors, an analysis revealed that patients who had received older blood had a significantly higher rate of combined serious adverse events than those who received newer blood. The study was published in the March 20, 2008, issue of the New England Journal of Medicine (NEJM).

"In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than two weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival,” concluded lead author Colleen Koch, M.D., M.S., and colleagues of the department of cardiothoracic anesthesia.

Previous studies have already raised questions about the shelf life of donated blood and attendant risks to patients. Some hospitals have brought in new procedures to minimize the use of donated blood during cardiac surgery, such as reducing anemia before surgery, using drugs to stop bleeding during and after surgery, collecting blood lost by the patient during surgery to be reused, and even discharging patients with a lower than normal RBC count.


Related Links:
Cleveland Clinic Foundation

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.